Gene · 4038
Papers1,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases. | Front Immunol | 2023 | 37781409 | PubTator, text mining | PubMed |
The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour. | Int J Mol Sci | 2023 | 37762403 | PubTator, text mining | PubMed |
| Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows. | Brain Sci | 2023 | 37759888 | PubTator, text mining | PubMed |
| Altered Cardiac Autonomic Regulation in Individuals with Myasthenia Gravis-A Systematic Review and Meta-Analysis. | Neurol Int | 2023 | 37755362 | PubTator, text mining | PubMed |
| A Comprehensive Literature Review on Managing Systemic Lupus Erythematosus: Addressing Cardiovascular Disease Risk in Females and Its Autoimmune Disease Associations. | Cureus | 2023 | 37727166 | PubTator, text mining | PubMed |
| Remission of severe myasthenia gravis after autologous stem cell transplantation. | Ann Clin Transl Neurol | 2023 | 37726935 | PubTator, text mining | PubMed |
| microRNAs delivered by small extracellular vesicles in MSCs as an emerging tool for bone regeneration. | Front Bioeng Biotechnol | 2023 | 37720323 | PubTator, text mining | PubMed |
| COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy. | Front Neurosci | 2023 | 37712090 | PubTator, text mining | PubMed |
| Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response. | Front Immunol | 2023 | 37705978 | PubTator, text mining | PubMed |
| Polymyositis: A Case Report. | Cureus | 2023 | 37700938 | PubTator, text mining | PubMed |
| The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability. | Cell Rep Med | 2023 | 37652015 | PubTator, text mining | PubMed |
| PROCEEDINGS OF THE XXIII CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: PadovaJune 8-10, 2023. | Acta Myol | 2023 | 37650038 | PubTator, text mining | PubMed |
| Myasthenia gravis after the third dose of human papillomavirus 9-valent vaccine: A case report. | Hum Vaccin Immunother | 2023 | 37643747 | PubTator, text mining | PubMed |
| New mutation in the β1 propeller domain of LRP4 responsible for congenital myasthenic syndrome associated with Cenani-Lenz syndrome. | Sci Rep | 2023 | 37640745 | PubTator, text mining | PubMed |
| Association between COVID-19 and myasthenia gravis (MG): A genetic correlation and Mendelian randomization study. | Brain Behav | 2023 | 37638499 | PubTator, text mining | PubMed |
| Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7. | Mol Ther Nucleic Acids | 2023 | 37637210 | PubTator, text mining | PubMed |
| D-Penicillamine-Induced Myasthenia Gravis-A Probable Complication of Wilson's Disease Treatment-A Case Report and Systematic Review of the Literature. | Life (Basel) | 2023 | 37629572 | PubTator, text mining | PubMed |
| Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types. | Int J Mol Sci | 2023 | 37628903 | PubTator, text mining | PubMed |
| Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics. | J Transl Med | 2023 | 37620910 | PubTator, text mining | PubMed |
| Increased Bone Formation and Accelerated Bone Mass Accrual in a Man Presenting with Diffuse Osteosclerosis/High Bone Mass Phenotype and Adenocarcinoma of Unknown Primary. | JBMR Plus | 2023 | 37614304 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4038/papers?page=12